Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $511.50 Million |
|---|---|
| Enterprise Value | $511.78 Million |
| Earnings per Share | $0.16 |
| Beta | 0.04 |
| Outstanding Shares | 50,000,000 |
| P/E Ratio | 33.8 |
|---|---|
| PEG | -0.29 |
| Price to Sales | - |
| Price to Book Ratio | 1.14 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -353.59 |
| Enterprise Value to Net Income | 39 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 31.49%▼ 59.47% |
|---|---|
| Total Invested | $160.33M▼ 64.96% |
| Investors Holding | 27▼ 43.00% |
Drugs Made In America Acquisition II Corp. currently lacks significant business operations. Its core objective is to execute a business combination, which may take various forms such as a merger, an acquisition of assets or shares, a rec...